Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Human Immunodeficiency Virus | Research

Risk indicators for oral ulcers among people living with HIV during the first wave of the pandemic: a cross sectional study

Authors: Morenike Oluwatoyin Folayan, Roberto Ariel Abeldaño Zuñiga, Jorma I. Virtanen, Nourhan M. Aly, Oliver C Ezechi, Joanne Lusher, Maha El Tantawi, Annie L Nguyen

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Little is currently known about HIV-related parameters that may increase the risk for oral ulcers during the COVID-19 pandemic. This study aimed to overcome this gap in research by assessing the associations between HIV viral load, antiretroviral adherence profile, co-morbidity status, SARS-CoV-2 infection and oral ulcers among people living with HIV (PLHIV).

Methods

This was a secondary analysis of data generated from 21,206 to 18 years and above, recruited from 152 countries through an online survey between July and December 2020. Data were extracted for 874 people who reported living with HIV. The dependent variable was reporting having oral ulcer. The independent variables were the viral load, adherence to antiretroviral treatment and a history of SARS-CoV-2 infection. The confounding variables were age at last birthday and sex at birth. A multivariable logistic regression analysis was conducted to determine the associations between the dependent and independent variables after adjusting for the confounding variables.

Results

Of the 874 participants, 99 (11.3%) reported having oral ulcers during the first wave of the COVID-19 pandemic. The odds of PLHIV having oral ulcers during the first wave of the COVID-19 pandemic was significantly higher for people who did not know their viral load than those who had undetectable viral load (AOR: 2.036; 95% CI: 1.204–3.443; p = 0.008); and people who did not adhere to the use of antiretroviral treatment than those who adhered (AOR: 4.113; 95% CI: 2.567–6.589; p < 0.001). Also, PLHIV who had SARS-CoV-2 infection had significantly higher odds of having oral ulcers than those who did not have the infection (AOR: 14.556; 95% CI: 4.500-47.078; p < 0.001). PLHIV who had co-morbidities had non-significantly higher odds of having oral ulcers than those without co-morbidities (AOR: 1.170; 95% CI: 0.656–2.085; p = 0.595).

Conclusion

Oral ulcers may be an indicator of poor adherence to antiretroviral therapy and unsuppressed viral load among PLHIV. It may also be an indicator of SARS-CoV-2 infection and a signal to take prompt and critical care of affected individuals because of the risk for severe COVID-19 for these individuals.
Appendix
Available only for authorised users
Literature
7.
go back to reference Meyerowitz EA, Kim AY, Ard KL et al. Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV. AIDS 2020; 34(12). Meyerowitz EA, Kim AY, Ard KL et al. Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV. AIDS 2020; 34(12).
18.
go back to reference Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179–84.CrossRefPubMed Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179–84.CrossRefPubMed
19.
go back to reference Brown TT, Li X, Cole SR, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS. 2005;19:1375–83.CrossRefPubMed Brown TT, Li X, Cole SR, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS. 2005;19:1375–83.CrossRefPubMed
31.
go back to reference Marg LZ, Heidari O, Taylor J, et al. A multidimensional assessment of successful aging among older people living with HIV in Palm Springs, California. AIDS Res Hum Retroviruses. 2019;35(11–12):1174–80.CrossRefPubMed Marg LZ, Heidari O, Taylor J, et al. A multidimensional assessment of successful aging among older people living with HIV in Palm Springs, California. AIDS Res Hum Retroviruses. 2019;35(11–12):1174–80.CrossRefPubMed
32.
go back to reference Wilson VanVoorhis CR, Morgan BL. Understanding power rules of thumb for determining sample sizes. Tutorials in Quantitative Methods for Psychology. 2007;3(2):43–50.CrossRef Wilson VanVoorhis CR, Morgan BL. Understanding power rules of thumb for determining sample sizes. Tutorials in Quantitative Methods for Psychology. 2007;3(2):43–50.CrossRef
36.
go back to reference Oyetola EO, Mogaji IK, Agho TO, Ayilara OA. Pattern of presentation of oral ulcerations in patients attending an oral medicine clinic in Nigeria. Ann Ib Postgrad Med. 2018;16(1):9–11.PubMedPubMedCentral Oyetola EO, Mogaji IK, Agho TO, Ayilara OA. Pattern of presentation of oral ulcerations in patients attending an oral medicine clinic in Nigeria. Ann Ib Postgrad Med. 2018;16(1):9–11.PubMedPubMedCentral
37.
go back to reference Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998;352:1510–4.CrossRefPubMed Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998;352:1510–4.CrossRefPubMed
41.
go back to reference Ehrenkranz PD, et al. The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings. PLoS Med. 2019;16(5):e1002820.CrossRefPubMedPubMedCentral Ehrenkranz PD, et al. The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings. PLoS Med. 2019;16(5):e1002820.CrossRefPubMedPubMedCentral
42.
go back to reference Little RJ. Regression with missing X’s: a review. J Am Stat Assoc. 1992;87(420):1227–37. Little RJ. Regression with missing X’s: a review. J Am Stat Assoc. 1992;87(420):1227–37.
43.
go back to reference Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445–8.CrossRefPubMed Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445–8.CrossRefPubMed
44.
go back to reference Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chic). 2009;8(6):367–74.CrossRefPubMed Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chic). 2009;8(6):367–74.CrossRefPubMed
46.
go back to reference Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–82.CrossRefPubMedPubMedCentral Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–82.CrossRefPubMedPubMedCentral
Metadata
Title
Risk indicators for oral ulcers among people living with HIV during the first wave of the pandemic: a cross sectional study
Authors
Morenike Oluwatoyin Folayan
Roberto Ariel Abeldaño Zuñiga
Jorma I. Virtanen
Nourhan M. Aly
Oliver C Ezechi
Joanne Lusher
Maha El Tantawi
Annie L Nguyen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03330-2

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue